Similar articles

• Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

  Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. Muñoz N, et al. Int J Cancer. 2004 Aug 20;111(2):278-85. doi: 10.1002/ijc.20244. Int J Cancer. 2004. PMID: 15197783
• Impact of human papillomavirus vaccination depends on effective vaccination strategy.

  Lehtinen M, Paavonen J. Lehtinen M, et al. Int J Cancer. 2009 Sep 15;125(6):1490-1. doi: 10.1002/ijc.24476. Int J Cancer. 2009. PMID: 19507251 No abstract available.
• Vaccination against multiple HPV types.

  Elbasha EH, Galvani AP. Elbasha EH, et al. Math Biosci. 2005 Sep;197(1):88-117. doi: 10.1016/j.mbs.2005.05.004. Math Biosci. 2005. PMID: 16095627
• [How technology and vaccination have changed the Pap test].

  Bondi A, Ghidoni D, Amadori A. Bondi A, et al. Pathologica. 1999 Feb;91(1):36-41. Pathologica. 1999. PMID: 10396949 Review. Italian. No abstract available.
• [A vaccine against papillomavirus infections and cancer].

  Lehtinen M, Apter D, Heikkilä R, Heino P, Idänpään-Heikkilä I, Rimpilä K, Malm C, Zilliacus R. Lehtinen M, et al. Duodecim. 2002;118(13):1397-404. Duodecim. 2002. PMID: 12239887 Review. Finnish. No abstract available.